REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

被引：0
|
作者：
Kaplan, D. [1 ]
Ung, B. [2 ]
Pelletier, C. [3 ]
Udeze, C. [3 ]
Tian, M. [3 ]
机构：
[1] Adult & Pediat Dermatol, Overland Pk, KS USA
[2] Celgene Corp, Morris Plains, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS14
引用
收藏
页码：S888 / S888
页数：1
相关论文
共 50 条
  • [41] Early use of vedolizumab vs. infliximab in biologic-naive patients with ulcerative colitis: A real-world analysis of healthcare utilisation
    Patel, H.
    Khalid, J. M.
    Shah, S.
    Shah, R.
    Berger, A.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S385 - S386
  • [42] OBSERVATIONAL STUDY COMPARING TREATMENT PERSISTENCE IN BIOLOGIC NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR ETANERCEPT
    Clancy, Z.
    Tencer, T.
    Kaura, S.
    Li, S.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A159 - A159
  • [43] PERSISTENCE AND ADHERENCE AT 12 MONTHS WITH SUBCUTANEOUSLY ADMINISTERED BIOLOGICS AMONG BIOLOGIC-NAIVE AND-EXPERIENCED PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSES FROM A US CLAIMS DATABASE
    Oelke, K. R.
    Chambenoit, O.
    Majjhoo, A. Q.
    Gray, S.
    Higgins, K.
    Hur, P.
    [J]. VALUE IN HEALTH, 2018, 21 : S201 - S201
  • [44] Healthcare Costs Associated with Serious Infections Among Biologic-Naive Rheumatoid Arthritis Patients Initiating First-Line Biologic Treatment.
    Johnston, S.
    Kelly, S.
    Nadkarni, A.
    Wilson, K.
    Limone, B.
    Hochberg, M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S501 - S502
  • [45] Real world tumor necrosis factor (TNF) blocker treatment patterns for biologic-naive psoriasis patients in a US managed care population
    Smith, Timothy
    Joyce, Amie
    Fox, Kathleen
    Gandra, Shravanthi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB10 - AB10
  • [46] Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center
    Zeb, Lawangeen
    Mhaskar, Rahul
    Lewis, Suzanna
    Patel, Nishit S.
    Sadhwani, Divya
    Patel, Nupur
    Ekhlassi, Erfon
    Lu, Yuanyuan
    Seminario-Vidal, Lucia
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [47] Real world use of ixekizumab is associated with reductions in concomitant medications among biologic-experienced or biologic-naive patients with psoriasis
    Wu, Jashin J.
    Zhu, Baojin
    Burge, Russel
    Goldblum, Orin
    Choong, Casey
    Edson-Heredia, Emily
    Amato, David
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB114 - AB114
  • [48] Effectiveness and safety of tocilizumab in monotherapy in biologic-naive and non-naive patients with rheumatoid arthritis in a real-world setting
    Marsal Barril, Sara
    Auxiliadora Martin-Martinez, Ma
    Javier Blanco-Garcia, Francisco
    Fernandez-Nebro, Antonio
    Garcia de Vicuna, Rosario
    Tornero-Molina, Jesus
    Sanchez-Alonso, Fernando
    Novella-Navarro, Marta
    Escudero-Contreras, Alejandro
    Jose Alegre-Sancho, Juan
    Urruticoechea-Arana, Ana
    Sagrario Bustabad-Reyes, Maria
    Trenor-Larraz, Pilar
    Perez-Sandoval, Trinidad
    Isabel Tevar-Sanchez, Maria
    Sanchez-Costa, Jesus T.
    Raya-Alvarez, Enrique
    [J]. REUMATOLOGIA CLINICA, 2022, 18 (10): : 567 - 573
  • [49] Real-world data study in health care costs from adults with psoriasis who initiated treatment with apremilast or biologics
    Wu, Jashin J.
    Wang, Ann
    Jobson, Greeta
    Davidson, David
    Kalirai, Samaneh
    Zhu, Julia
    Suryavanshi, Manasi
    Mittal, Mayank
    Patel, Vardhaman
    Seigel, Lauren
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB198 - AB198
  • [50] Real-World Use of Secukinumab Among Biologic-NaiVe and Biologic-Experienced Patients with Ankylosing Spondylitis in the United States
    Oelke, Kurt R.
    Garg, Rahul
    Li, Yunfeng
    Liu, Xing
    Zhou, Huanxue
    Park, Yujin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345